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which block meiosis at metaphase I. We postulate that lesions 
within the oocyte's developmental programme are major 
causes of embryonic mortality. For example, alterations to pre-
ovulatory steroid profiles selectively disrupt protein reprogram-
ming and individual components of the fertilization process. 
Similarly, some proteins secreted during maturation appear to 
facilitate early embryogenesis, whilst the role of others is at 
present unknown, although they bind to specific oocyte recep-
tors. We postulate that it will be through a more complete 
understanding of somatic signals and developmental responses 
that early embryonic viability will be enhanced. 
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Infertility in men can be produced by a wide variety of 
drugs and chemicals. Several have been considered as male 
contraceptives (a-chlorohydrin, win 18446 and gossypol) but 
none have reached clinical acceptance. The therapeutic ratio 
must be extraordinarily high for a compound used for social 
rather than medical reasons. Whilst hormonal contraception 
remains a favoured route and immunological approaches hold 
great promise, they are certainly not ideal and other targets 
should be sought. The goal is to find a compound which will 
produce safe, rapid, reliable and reversible infertility. One 
route is to empirically screen compounds and hope that 
serendipity takes a hand, as in the search for the contraceptive 
constituents (diterpenes) of the plant Tripterygium wilfordi. 
However, modem drug development harnesses the powerful 
techniques of molecular biology and, after identifying the 
target, millions of compounds from traditional or combinatorial 
chemical libraries can be screened in a very short time. If 
progress is to be made, then targets must be identified and 
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evaluated. The search is encouraging as the testis and epididy-
mis carry out many unique processes to transform the spermato-
gonial stem cell into a fertilizing spermatozoon. Some of these 
can illustrate the potential for contraceptive intervention. 
Programmed cell death (apoptosis) is an important regulator 
of germ cell numbers, particularly the meiotic spermatocyte. 
Chemicals such as methoxyacetic acid precipitate germ cell 
apoptosis, demonstrating that the signal transduction systems 
are in place although they are unknown. The Bcl-2 gene 
family, a target for cancer chemotherapy, may be involved and 
leads may arise from this arena. Another target is spermiation, 
when the Sertoli cell releases the mature germ cell into the 
tubular lumen. That this approach is possible can be shown 
by the antifertility effects of boric acid, which occur before 
any disruption of spermatogenesis. The epididymis is perhaps 
the most desirable target for male contraception because here 
the onset and recovery of infertility will be the fastest. Infertile 
men often possess mutations in the cystic fibrosis gene, which 
codes for a transmembrane conductance regulator involving a 
chloride channel, which suggests that secretion is a good 
target. Blockade of an ATPase proton pump neutralizes the 
pH of the epididymal fluid and renders the spermatozoa 
infertile. In conclusion, the possibility of the development 
of a non-steroidal male contraceptive remains. Progress is 
dependent on identifying molecular targets (enzymes, recep-
tors) against which chemicals can be screened. This will only 
be achieved by appropriate financial investment, which may 
have to be driven by social and demographic priorities. 
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Mammalian embryos will initiate implantation-type reactions 
in many different non-uterine sites. Thus the embryo 
expresses an intrinsic invasive potential. Most of the time 
this is not true for the endometrium because it protects 
itself from implantation, except during a limited period 
known as the implantation window. After the initial steps 
of implantation, trophoblast invasion is also controlled by 
endometrial signals. Medium conditioned by decidual cells 
inhibits the invasion of trophoblast cells in the amnion 
invasion assay. These effects seem to be caused by cytokines. 
We examined the effects of decidual cell-conditioned medium 
(DCM), IGFBP-l (the major secretory product of decidual 
cells) and different cytokines of endometrial origin on the 
secretion of trophoblastic gelatinases [matrix metallo-
proteinase (MMP)-2 and MMP-9] and their inhibitor (TIMP-
1). First-trimester cytotrophoblastic cells were obtained from 
abortions and cultured in vitro in presence or absence of 
DCM, IGFBP-l or different cytokines. Secreted gelatinases 
were analysed in the culture supernatants by zymography 
and measurement of the total gelatinolytic activity. TIMP-
1, HCG and fetal fibronectin (fFN) were measured using 
commercially available immunoassays. DCM inhibited the 
total gelatinolytic activity of cytotrophoblastic cells but 
increased trophoblastic MMP-9, TIMP-l and fFN. In contrast, 
IGFBP-l increased the total gelatinolytic activity, and TIMP-
1 had no effect on MMP-2, MMP-9 or fFN. TGF-~ inhibited 
the total gelatinolytic activity of cytotrophoblastic cells and 
this effect was mainly due to an inhibition of MMP-9. In 
contrast, TNF increased the total gelatinolytic activity and 
MMP-9 but decreased MMP-2 and fFN. Macrophage colony-
stimulating factor had no effect on the parameters studied. 
We conclude that decidual cells exert a profound effect on 
the proteolytic activity of trophoblast cells. Although these 
results explain the effects of decidual cell supernatants on 
trophoblastic invasion, a complete understanding of how 
endometrial cytokines interact to modulate trophoblastic 
invasion is still lacking. 
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Successful implantation of the placenta is dependent on the 
correct degree of trophoblast invasion into the uterine 
decidua. The extent of this invasion is tightly controlled. 
Under-invasion will lead to inadequate transformation of the 
decidual spiral arteries, resulting in clinical conditions such 
as miscarriage, intrauterine growth retardation or pre-
eclampsia. Over-invasion is exemplified by placenta percreta. 
The factors that control trophoblast invasion are not known. 
Because placental trophoblast cells are derived from the 
antigenic ally 'foreign' fetus, it is likely that there could be 
an immunological mechanism of control similar to that 
which occurs between a transplanted allograft and recipient. 
Surprisingly, recent evidence indicates that the immunological 
mechanism in implantation appears to be based on a 
population of maternal natural killer (NK) cells rather than 
T cells, as in organ transplantation. Furthermore, these NK 
cells probably interact with a classic human leukocyte 
antigen (HLA) class I antigen (HLA-C) and a non-classic 
HLA class I antigen (HLA-G) expressed by invading 
trophoblast, instead of the usual HLA-A and HLA-B 
expressed by other somatic cells. This would appear to 
be a novel allo-recognition system unlike that seen III 
transplantation immunology, and is now a major focus. of 
research interest. 
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Introduction: To assess the genetic consequences of ICSI 
in male subfertility couples, most centres perform routine 
cytogenetic analyses of the male patient. In our ICSI pro-
gramme, chromosome investigations are performed in all male 
patients and their wives prior to the initiation of ICSI treatment. 
Here we report on ICSI results in patients where constitutional 
or single cell chromosome aberrations were detected in the 
male and/or female partner. 
Materials and methods: In a collaborative approach, all 
patients are counselled to undergo an extended andrological, 
gynaecological and cytogenetic examination prior to ICSI. 
This study was based on the evaluation of 434 couples who 
received ICSI treatment. The selection for ICSI was based on 
severe male factor infertility and/or previous fertilization failure 
in an IVF attempt with the absence of a female factor. 
Results: Out of 434 couples treated by ICSI, 16 were affected 
by constitutional chromosome aberrations (eight male and 
eight female patients) and 96 by single cell chromosome 
aberrations (22 males, 59 females and both partners in 15 
couples). In all, 322 couples were unaffected and were regarded 
as the control group. In the group with constitutional chromo-
some aberrations we performed 30 treatment cycles. When 
compared with a matched control group, couples with the male 
affected (20 cycles) showed significantly lower fertilization, 
implantation and pregnancy rates. In the female group (10 
cycles), fertilization, implantation and pregnancy rates were 
comparable with the control group but a high abortion rate 
(two out of three pregnancies) was noted. Couples affected by 
single cell chromosomal aberrations received 166 treatment 
cycles with 48 male-affected cycles, 96 female-affected cycles 
and 22 cycles where both partners showed an abnormality. 
Fertilization and transfer rates were significantly lower when 
compared with the remaining (unaffected) 322 couples (394 
cycles), whereas implantation and pregnancy rates proved to 
be comparable. In all couples suffering an abortion mainly 
parental autosomal aberrations were involved (six out of eight). 
Conclusion: An unexpectedly high number of infertile couples 
in our ICSI programme are affected by chromosome 
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